NDC 55513-670

AVSOLA

Infliximab-axxq

AVSOLA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Infliximab.

Product ID55513-670_9e52c098-cdca-4456-84d0-e7d4f5324579
NDC55513-670
Product TypeHuman Prescription Drug
Proprietary NameAVSOLA
Generic NameInfliximab-axxq
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-12-12
Marketing CategoryBLA / BLA
Application NumberBLA761086
Labeler NameAmgen Inc
Substance NameINFLIXIMAB
Active Ingredient Strength100 mg/10mL
Pharm ClassesTumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 55513-670-01

1 VIAL, SINGLE-DOSE in 1 CARTON (55513-670-01) > 10 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2019-12-12
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
INFLIXIMAB100 mg/10mL

Pharmacological Class

  • Tumor Necrosis Factor Blocker [EPC]
  • Tumor Necrosis Factor Receptor Blocking Activity [MoA]

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.